Bruce Prenner, AAAAI 2022: Results from a Chronic Cough Survey of Allergy Specialists
It was a delight to catch up with Dr. Bruce Prenner (Allergy Associates Medical Group Inc., San Diego, CA, USA) to discuss the findings from a survey investigating referral sources, etiology, prevalence, symptoms and treatments in chronic cough patients.
The abstract ‘Chronic Cough: Referral Sources, Etiology, Prevalence, Symptoms and Treatments In Adults A Survey of Allergy Specialists‘ was presented at AAAAI 2022, 25-28 February.
Questions
- What was the rationale for and design of your survey? (0:33)
- What were the most common symptoms and complaints of people living with chronic cough? (2:24)
- What were the most common treatments, and how effective were they? (4:35)
- On the basis of these findings, what unmet needs have been identified and what future actions should be taken? (7:03)
Disclosures: Bruce Prenner is a consultant for ALK, Merck; has received grant/ research support from Merck, Bellus, Shionogi, Teva, Aldeyra Therapeutics; has served on advisory boards for Merck; and has participated in speaker’s bureaus for Optinose, ALK, Merck.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
Filmed in coverage of the AAAAI annual meeting 2022.
